Linking two enzymes turns plastic-eating bacteria into super-digesters
Plastic is everywhere. Scientists have found tiny bits of microplastic even in the extremes of the Earth – from the deep-sea of the Mariana Trench to the peaks of the Pyrenees – and damaging life around us. While source reduction can be one of the most effective ways to reduce plastic waste, how do we deal with all of the plastic that already exists, polluting our oceans and overflowing out of landfills?

Polyethylene terephthalate, also known as PET and one of the most common types of plastic, is unfortunately notoriously difficult to break down. In 2016 however, scientists found a new species of bacteria outside of a bottle-recycling facility capable of decomposing plastic. The discovery revealed that the bacteria's abilities depend on two specific enzymes. These enzymes work together in a two-step process to break plastic down into smaller molecules that the bacteria can turn into energy.
A new study published in the Proceedings of the National Academy of Sciences demonstrates a way to improve the two-enzyme system. While naturally existing as two separate enzymes – PETase and MHETase – the researchers physically linked them together. The attached enzymes worked together more efficiently than the same two enzymes when unlinked. Depending on the length of the linking segment between them, the attached enzymes were able to release almost double the amount or more of the final broken down product.
With this process, PET, could be broken down by the bacteria in days, a process which would take hundreds of years in the environment.
But breaking down plastic only deals with part of the issue of plastic waste. Recovering the plastic waste already in the ocean and other corners of the planet to deliver to recycling or decomposing facilities remains a daunting challenge. And even faced with the knowledge that we need to reduce plastic, the world has only been ramping up its production levels. Although these results are exciting, we're still far from solving our growing plastic problem.
This story originally appeared on Massive Science, an editorial partner site that publishes science stories by scientists. Subscribe to their newsletter to get even more science sent straight to you.

Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Omega-3 fats linked to healthy aging and improved heart metabolism
Scientists from the University of Iowa find that a diet high in polyunsaturated fatty acids from fish oil increases cardiac triglyceride uptake and improves insulin sensitivity. Read more about this recent JLR study.

RA patient blood reveals joint innerworkings
Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.